The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
A Comparison of the Use of Clinical-Guideline–Recommended Antihypertensive Regimens in Mexican American, Non-Hispanic Black, and Non-Hispanic White Adults With Type 2 Diabetes and Hypertension in the United States: NHANES 2003-2012
Abstract
Purpose: The purpose of this study was to determine the use of clinical-guideline–recommended antihypertensive regimens among Mexican Americans (MAs) and non-Hispanic blacks and whites with type 2 diabetes and hypertension. Methods: A secondary data analysis based on National Health and Nutrition Examination Survey 2003-2012 cohort data included 1857 noninstitutionalized civilian MA, black, and white adults with type 2 diabetes and hypertension. Unadjusted and adjusted 2-way analysis of variance models evaluated whether there was a difference in the use of recommended antihypertensive regimens across race/ethnic group. Results: There was no difference in the use of recommended regimens across race/ethnic group (MAs, 79.1%; blacks, 81.7%; whites, 82.3%). Similarly, there was no difference between blood pressure goal levels and the use of recommended therapies across race/ethnicity ( P = .632). Mexican Americans were least likely and blacks most likely to be on 3 or more antihypertensive drug classes (16.8% vs 28%). Furthermore, MAs were least likely to be on recommended add-on therapies such as calcium channel blockers and diuretics. Conclusion: Racial/ethnic medication use disparities were observed when looking at the number of antihypertensive drug classes per patient regimen, and add-on therapy use was evaluated. Along with lifestyle modifications, frequent antihypertensive regimen reassessment is necessary.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The selection of medications to lower BP in persons with T2D should be guided by individual-specific considerations and may include nontraditional BP-lowering agents such as SGLT2is and GLP-1 RAs, though these drugs alone may be inadequate to control BP.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [244]
Citations
Cites
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271 · cited 5×
“All clinical guidelines have recommended that physicians follow up with their patients to reassess treatment every 4 weeks until blood pressure is controlled.(8,9) Once this is achieved, 3- to 6-month interval reassessments are appropriate.”
BackgroundMethodInfluentialJames, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Factors affecting therapeutic compliance: A review from the patient’s perspective
Li, S.-C. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1458 · Cited by 1,265 · cited 1×
“There are a limited number of studies that evaluate the relationship of the total number of medications taken and drug adherence, and results are mixed.(21) One important physicianspecific factor is frequency of pharmacotherapy monitoring and reassessment of blood pressure control.”
BackgroundWeber, M. A., Schiffrin, E. L., White, W. B., Mann, S., Lindholm, L. H., Kenerson, J. G., Flack, J. M., Carter, B. L., Materson, B. J., Ram, C. V. S., et al. (2014) · The Journal of Clinical Hypertension · doi:10.1111/jch.12237 · Cited by 986
Treatment of Hypertension in Adults With Diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s80 · Cited by 497
Comparing self-reported and physician-reported medical history
Kehoe, R., Wu, S.-Y., Leske, M. C., & Chylack, L. T. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117078 · Cited by 441 · cited 1×
“However, 1 study showed that patient self-report of diabetes history and medication use is accurate when compared to medical records.(25) Third, antihypertensive dose strengths were not available, so dose maximization could not be determined as a regimen quality outcome.”
ResultThe Treatment of Hypertension in Adult Patients With Diabetes
Arauz-Pacheco, C., Parrott, M. A., & Raskin, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.134 · Cited by 326
Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population
Boccuzzi, S. J., Wogen, J., Fox, J., Sung, J. C. Y., Shah, A. B., & Kim, J. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1411 · Cited by 180
Desai, N. R., Shrank, W. H., Fischer, M. A., Avorn, J., Liberman, J. N., Schneeweiß, S., Pakes, J., Brennan, T. A., & Choudhry, N. K. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.07.033 · Cited by 151
Diabetes and Hypertension: Pathogenesis, Prevention and Treatment
Landsberg, L., & Molitch, M. E. (2004) · Clinical and Experimental Hypertension · doi:10.1081/ceh-200031945 · Cited by 113 · cited 1×
“It has been reported that 50% to 80% of individuals with type 2 diabetes have hypertension.(1) Patients with both diabetes and hypertension are at a much higher risk of having uncontrolled blood pressure and are more likely to suffer from cardiovascular and renal complications.”
Background
Research works printed but not linked: 3
- Valderrama AL, 2013, Morb Mortal Wkly Rep, 62, 351
- Lora CM, 2013, Ethnic Dis, 23, 189
- Johnson CL, 2013, Vital Health Stat Ser 2, Data Eval Methods Res, 161, 1
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Gu, A., Farzadeh, S., Chang, Y. J., Kwong, A., & Lam, S. (2019) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546819839418 · Cited by 11
Perioperative Glycemic Control for Patients Undergoing Coronary Artery Bypass Grafting
Luo, C., Wang, C., Xie, X., & Zheng, B. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103897 · Cited by 1
Shah, H. K., Shah, M. K., Patel, H., Maslekar, A. A., & Kanzariya, T. (2025) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_2_25 · Cited by 1
Mackett, K., Sherifali, D., de Souza, R. J., Kalra, M. S., Ramos-Acevedo, S., Cameron, R. S., & Santesso, N. A. (2026) · Primary care diabetes · doi:10.1016/j.pcd.2026.07.003
Metadata
- Authors
- Perez, A., Levin, A., & Alam, N.
- Affiliations
- Sociobehavioral and Administrative Pharmacy Department, Nova Southeastern University College of Pharmacy, Davie, Florida (Dr Perez)
- Nova Southeastern University (US)
- ORCID
- Levin, Andrea
- Venue
- The Diabetes Educator
- Publisher
- SAGE Publications
- Published
- 2016-09-24
- Volume
- 42
- Issue
- 6
- Pages
- 739-747
- ISSN
- 0145-7217 (ISSN-L)
- 1554-6063
- OpenAlex
- W2519436163
- Cited by
- 5
- References
- 22
- Citations by year
- 2026: 1 · 2025: 1 · 2022: 2 · 2019: 1
- FWCI
- 0.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- The Science of Diabetes Self-Management and Care (publishedVersion)
- PubMed (publishedVersion)
- NSUWorks (Nova Southeastern University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- antihypertensive regimens, hypertension, type 2 diabetes, Mexican Americans, non-Hispanic Black adults, racial and ethnic disparities, guideline adherence, blood pressure targets, add-on antihypertensive therapy, calcium channel blockers, diuretics, medication use
- MeSH terms
- Adult, Antihypertensive Agents, Black or African American, Diabetes Mellitus, Type 2, Female, Humans, Hypertension, Male, Middle Aged, Nutrition Surveys, United States, Mexican Americans, Practice Guidelines as Topic, Guideline Adherence, White People, Healthcare Disparities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Comparison of the Use of Clinical-Guideline–Recommended Antihypertensive Regimens in Mexican American, Non-Hispanic Black, and Non-Hispanic White Adults With Type 2 Diabetes and Hypertension in the United States: NHANES 2003-2012. https://app.cochat.ai/papers/10.1177/0145721716666680
- The paper
- Perez, A., Levin, A., & Alam, N. (2016). A Comparison of the Use of Clinical-Guideline–Recommended Antihypertensive Regimens in Mexican American, Non-Hispanic Black, and Non-Hispanic White Adults With Type 2 Diabetes and Hypertension in the United States: NHANES 2003-2012. The Diabetes Educator. https://doi.org/10.1177/0145721716666680
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.